吡喹酮诊断性治疗疑似脑囊尾蚴病的临床应用  

Clinical application of diagnostic therapy of praziquantel for suspected cerebral cysticercosis

作　　者：李彦[1] 孙黎[1] 陈闯[1] 杨春梅[1] 

机构地区：[1]四川省疾病预防控制中心,成都610041

出　　处：《中国血吸虫病防治杂志》2015年第5期517-519,共3页Chinese Journal of Schistosomiasis Control

摘　　要：目的探讨吡喹酮诊断性治疗在疑似脑囊尾蚴病中的应用价值。方法收集疑似脑囊尾蚴病病例进行诊断性治疗,以吡喹酮50 mg/（kg·d）,分3次服用,每个疗程10~12天,治疗3~5个疗程,并进行1~2年的随访观察,评价疗效。结果共收集到94例疑似脑囊尾蚴病病例,其中78例（占82.98%）经诊断性治疗确诊为脑囊尾蚴病,13例（占13.83%）排除脑囊尾蚴病可能,另外3例（3.19%）未能明确诊断。结论吡喹酮诊断性治疗能减少非典型脑囊尾蚴病患者的漏诊和误诊。Objective To explore the clinical application value of diagnostic therapy of praziquantel for suspected cerebral cysticercosis. Methods The suspected cerebral cysticercosis patients were collected and treated with the diagnostic therapy[praziquantel,50 mg/（kg·d）],and followed up for 1-2 years. Results Totally 94 suspected cerebral cysticercosis patients were collected. After the diagnostic therapy,78（82.98%）cases were confirmed as cerebral cysticercosis,13（13.83%）were diagnosed as other diseases,and 3（3.19%）were not definitely diagnosed. Conclusion The diagnostic therapy for suspected cerebral cysticercosis can reduce or avoid the missed diagnosis and misdiagnosis in some atypical cerebral cysticercosis patients.

关 键 词：脑囊尾蚴病 诊断性治疗 疑似病例 吡喹酮 

分 类 号：R532.33[医药卫生—内科学]